DHDenise Head

Denise Head

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Denise Head has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Understanding the return journey: Determinants of route retracing in younger and older adults.

    by Denise Head, Hannah Maybrier, Marta Stojanovic, Taylor F. Levine, Cheyenne Parson

    Route retracing (i.e., returning to your start location) is critical for successful navigation in everyday life. While age-related impairment in traversing a route from a start location to target destination has been well-established, age differences in the ability to reverse a previously learned path has been less examined. Previous work found that studying a map facilitates better route retracing for older adults than studying a route from an egocentric perspective during initial learning. However, the mechanism for this benefit is unclear. This study examined whether facilitating allocentric representation, egocentric perspective taking, or temporal sequencing would benefit route retracing performance in younger (n = 69; aged 18-36) and older (n = 70; aged 61-85) adults. In addition, the role of individual differences in allocentric representation development, egocentric perspective taking, temporal sequencing, procedural learning, as well as hippocampal and caudate volume in route performance was examined. Older adults benefited from developing an allocentric representation of the environment and simultaneous exposure to landmark temporal order when reversing a route but did not show a benefit from minimizing demands on egocentric perspective taking. Both cognitive map formation and egocentric perspective taking tasks were each more strongly associated with route retracing than route repetition across age groups. Results suggest that older adults may benefit from specific strategies to develop and retain a flexible environmental representation, which would allow for successful route retracing. (PsycInfo Database Record (c) 2025 APA, all rights reserved).


  • Influence of sleep and cardiovascular health on cognitive trajectories in older adults

    by Hannah R. Maybrier, Joshua J. Jackson, Cristina D. Toedebusch, Brendan P. Lucey, Denise Head


  • Role of Cardiovascular Risk in Associations of Brain-Derived Neurotrophic Factor with Longitudinal Brain and Cognitive Trajectories in Older Adults

    by Jennifer Shearon, Joshua Jackson, Denise Head, For The Alzheimer’s Disease Neuroimaging Initiative

    Higher levels of brain-derived neurotrophic factor (BDNF) have been associated with better neurocognitive outcomes. BDNF is present in cardiovascular tissue, and some evidence suggests it may benefit cardiovascular function. The current study assessed whether there is a mediating and/or moderating role of cardiovascular health in the relationship between BDNF and brain and cognitive outcomes. We examined longitudinal data from 397 older adults (aged 54-89;164 females, 233 males) enrolled in the Alzheimer's Disease Neuroimaging Initiative with available plasma BDNF, medical, neuroimaging, and cognitive assessments. We used path analysis and linear regression to estimate the mediating and moderating roles of two measures of cardiovascular health, the Framingham Risk Score (FRS) and pulse pressure, in the relationships between BDNF and longitudinal changes in brain structure (white matter hyperintensity volume, hippocampal volume, and primary visual cortex volume) and cognitive function (executive function, episodic memory, and language). There was no significant association of plasma BDNF with FRS or pulse pressure (ps > 0.31), precluding mediation. There were no robust associations between BDNF and longitudinal change in any brain structural or cognitive measures (ps > .12). Higher FRS was significantly associated with greater increases in WMH volume (ps < .01). FRS and pulse pressure were not associated with any other brain structural or cognitive outcomes (ps > .07). These results suggest that cardiovascular health may not play an important role in the influence of BDNF on neurocognitive health in older adults.


  • Open Access

    Spatial navigation, physical activity, and Alzheimer disease biomarkers

    by Marta Stojanovic, Samantha L. Allison, Suzanne E. Schindler, Denise M Head

    Background: Elevated levels of amyloid are associated with worse performance on cognitive mapping (CM), a spatial navigation task reliant on the hippocampus. Prior animal work found that exercise is associated with better learning in CM tasks. Hence, the first goal of the study was to examine whether physical activity moderates the relationship between amyloid deposition and CM. In addition, spatial navigation ability predicts Alzheimer disease (AD) clinical progression but there is a need to examine whether it also predicts subsequent levels of amyloid and tau. Hence, the second goal was to examine whether CM predicts later levels of PET‐Tau and longitudinal trajectories of PET‐Amyloid.Method: Cognitively normal individuals (n = 65; age range 50‐84 years) were administered a CM task in a virtual environment and a self‐report measure of physical activity. For cross‐sectional analyses, amyloid deposition was estimated via cerebrospinal fluid levels of Aβ42. One assessment of PET‐Tau (n = 49) and repeated assessments of PET‐Amyloid (n = 59) were obtained following the CM session.Result: Concurrent amyloid deposition was associated with reduced learning (p = 0.002) and retention of the environment (p = 0.002) while greater physical activity was associated with better learning (p = 0.004). There was no moderation by physical activity (all p’s > 0.156). CM performance was not associated with longitudinal trajectories of PET‐Amyloid (all p’s > 0.330) or the subsequent levels of PET‐Tau (all p’s > 0.572).Conclusion: These results suggest that both current physical activity and levels of amyloid can be important predictors of spatial navigation skills. However, CM might be a limited predictor of AD biomarker accumulation. Future studies should use a larger sample size and greater number of assessments to examine these questions.

  • Open Access

    Alzheimer disease biomarkers are associated with decline in subjective memory, attention, and spatial navigation ability in clinically normal adults

    by Taylor F. Levine, Steven J. Dessenberger, Samantha L. Allison, Denise Head, The Alzheimer’s Disease Neuroimaging Initiative

    Objective: Subtle changes in memory, attention, and spatial navigation abilities have been associated with preclinical Alzheimer disease (AD). The current study examined whether baseline AD biomarkers are associated with self- and informant-reported decline in memory, attention, and spatial navigation.Method: Clinically normal (Clinical Dementia Rating Scale (CDR®) = 0) adults aged 56–93 (N = 320) and their informants completed the memory, divided attention, and visuospatial abilities (which assesses spatial navigation) subsections of the Everyday Cognition Scale (ECog) annually for an average of 4 years. Biomarker data was collected within (±) 2 years of baseline (i.e., cerebrospinal fluid (CSF) p-tau181/Aβ42 ratio and hippocampal volume). Clinical progression was defined as CDR > 0 at time of final available ECog.Results: Self- and informant-reported memory, attention, and spatial navigation significantly declined over time (ps < .001). Baseline AD biomarkers were significantly associated with self- and informant-reported decline in cognitive ability (ps < .030), with the exception of p-tau181/Aβ42 ratio and self-reported attention (p = .364). Clinical progression did not significantly moderate the relationship between AD biomarkers and decline in self- or informant-reported cognitive ability (ps > .062). Post-hoc analyses indicated that biomarker burden was also associated with self- and informant-reported decline in total ECog (ps < .002), and again clinical progression did not significantly moderate these relationships (ps > .299).Conclusions: AD biomarkers at baseline may indicate risk of decline in self- and informant-reported change in memory, attention, and spatial navigation ability. As such, subjectively reported decline in these domains may have clinical utility in tracking the subtle cognitive changes associated with the earliest stages of AD.


  • Open Access

    Clinical utility of self- and informant-reported memory, attention, and spatial navigation in detecting biomarkers associated with Alzheimer disease in clinically normal adults

    by Taylor F. Levine, Samantha L. Allison, Steven J. Dessenberger, Denise Head, For The Alzheimer’s Disease Neuroimaging Initiative

    Objective: Preclinical Alzheimer disease (AD) has been associated with subtle changes in memory, attention, and spatial navigation abilities. The current study examined whether self- and informant-reported domain-specific cognitive changes are sensitive to AD-associated biomarkers.Method: Clinically normal adults aged 56–93 and their informants completed the memory, divided attention, and visuospatial abilities (which assesses spatial navigation) subsections of the Everyday Cognition Scale (ECog). Reliability and validity of these subsections were examined using Cronbach’s alpha and confirmatory factor analysis. Logistic regression was used to examine the ability of ECog subsections to predict AD-related biomarkers (cerebrospinal fluid (CSF) ptau181/Aβ42 ratio (N = 371) or hippocampal volume (N = 313)). Hierarchical logistic regression was used to examine whether the self-reported subsections continued to predict biomarkers when controlling for depressive symptomatology if available (N = 197). Additionally, logistic regression was used to examine the ability of neuropsychological composites assessing the same or similar cognitive domains as the subsections (memory, executive function, and visuospatial abilities) to predict biomarkers to allow for comparison of the predictive ability of subjective and objective measures.Results: All subsections demonstrated appropriate reliability and validity. Self-reported memory (with outliers removed) was the only significant predictor of AD biomarker positivity (i.e., CSF ptau181/Aβ42 ratio; p = .018) but was not significant when examined in the subsample with depressive symptomatology available (p = .517). Self-reported memory (with outliers removed) was a significant predictor of CSF ptau181/Aβ42 ratio biomarker positivity when the objective memory composite was included in the model.Conclusions: ECog subsections were not robust predictors of AD biomarker positivity.


  • Associations of environmental and lifestyle factors with spatial navigation in younger and older adults

    by Hannah Maybrier, Ben Julian A. Palanca, Denise Head

    Objective: Advanced age is associated with prominent impairment in allocentric navigation dependent on the hippocampus. This study examined whether age-related impairment in allocentric navigation and strategy selection was associated with sleep disruption or circadian rest-activity fragmentation. Further, we examined whether associations with navigation were moderated by perceived stress and physical activity.Method: Sleep fragmentation and total sleep time over the course of 1 week were assayed in younger (n= 42) and older (n= 37) adults via wrist actigraphy. Subsequently, participants completed cognitive mapping and route learning tasks, as well a measure of spontaneous navigation strategy selection. Measurements of perceived stress and an actigraphy-based index of physical activity were also obtained. Circadian rest-activity fragmentation was estimated via actigraphy post-hoc.Results: Age was associated with reduced cognitive mapping, route learning, allocentric strategy use, and total sleep time (ps < .01), replicating prior findings. Novel findings included that sleep fragmentation increased with advancing age (p= .009) and was associated with lower cognitive mapping (p= .022) within the older adult cohort. Total sleep time was not linearly associated with the navigation tasks (ps > .087). Post-hoc analyses revealed that circadian rest-activity fragmentation increased with advancing age within the older adults (p= .026) and was associated with lower cognitive mapping across the lifespan (p= .001) and within older adults (p= .005). Neither stress nor physical activity were robust moderators of sleep fragmentation associations with the navigation tasks (ps > .113).Conclusion: Sleep fragmentation and circadian rest-activity fragmentation are potential contributing factors to age effects on cognitive mapping within older adults.


  • Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease

    by Taylor F. Ma Levine, Catherine M. Roe, Ganesh M. PhD Babulal, Anne M. Fagan, Denise Head

    Subtle changes in objective spatial navigation ability have been observed in the preclinical stage of Alzheimer disease (AD) cross-sectionally and have been found to predict clinical progression. However, longitudinal change in self-reported spatial navigation ability in preclinical AD has yet to be examined. The current study examined whether AD biomarkers suggestive of preclinical AD at baseline spatial navigation assessment and APOE genotype predicted decline in self-reported spatial navigation ability and whether APOE genotype moderated the association of AD biomarkers with change in self-reported spatial navigation. Clinically normal (Clinical Dementia Rating Scale=0) adults aged 56 to 90 completed the Santa Barbara Sense of Direction Scale (SBSOD) annually for an average of 2.73 years. Biomarker data was collected within +/−2 years of baseline (ie, cerebrospinal fluid Aβ42, p-tau181, p-tau181/Aβ42 ratio, positron emission tomography imaging with Florbetapir or Pittsburgh Compound-B, and hippocampal volume). APOE genotyping was obtained for all participants. SBSOD demonstrated a nonsignificant trend toward a decline over time (P=0.082). AD biomarkers did not predict change in self-reported spatial navigation (all Ps>0.163). APOE genotype did not moderate the relationship between AD biomarkers and self-reported spatial navigation in planned analyses (all Ps>0.222). Results suggest that self-reported spatial navigation ability, as estimated with the SBSOD, may be limited as a measure of subtle cognitive change in the preclinical stage of AD.


  • Open Access

    Spatial navigation ability predicts progression of dementia symptomatology

    by Taylor F. Levine, Samantha L. Allison, Marta Stojanovic, Anne M. Fagan, John C. Morris, Denise Head

    Introduction: Spatial navigation deficits are observed in Alzheimer's disease cross‐sectionally, but prediction of longitudinal clinical decline has been less examined.Methods: Cognitive mapping (CM) was assessed in 95 participants and route learning (RL) was assessed in 65 participants at baseline. Clinical progression over an average of 4 to 5 years was assessed using the clinical dementia rating (CDR) scale. Relative predictive ability was compared to episodic memory, hippocampus, and cerebrospinal fluid biomarkers (phosphorylated tau/amyloid β 42 (ptau181/Aβ42) ratio).Results: CM and RL were predictors of clinical progression (P’s < 0.032). All measures, except RL‐Learning remained predictors with episodic memory in models (P’s < 0.048). Only RL‐Retrieval remained a predictor when ptau181/Aβ42 was included (P < 0.001). CM interacted with hippocampus and ptau181/Aβ42 in prediction (P’s < 0.013). CM, RL, and episodic memory evidenced strong diagnostic accuracy (area under the curve (AUC) = 0.894, 0.794, and 0.735, respectively); CM tended to perform better than episodic memory (P = 0.056).Discussion: Baseline spatial navigation performance may be appropriate for assessing risk of clinical progression.


  • Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning

    by Marta Stojanovic, Yuxuan Jin, Anne M. Fagan, Tammie L. Benzinger, Jason Hassenstab, Carlos Cruchaga, John C. Morris, Denise Head

    Introduction: Associations of physical exercise with Alzheimer disease (AD) biomarkers and cognitive functioning have been observed cross-sectionally. However, the effects of exercise on longitudinal change in AD biomarkers have not been thoroughly investigated. The current study examined whether individuals with higher baseline exercise exhibited less longitudinal change in AD biomarkers and cognitive functioning, and whetherAPOEand/or brain-derived neurotrophic factor (BDNF) genotypes moderated the effects of exercise on longitudinal changes.Methods: Clinically normal individuals completed a questionnaire on physical exercise over the prior 10-year period at baseline. Ninety-five individuals had serial cerebrospinal fluid samples collected to examine Aβ42, ptau181and total tau; 181 individuals underwent multiple assessments of amyloid positron emission tomography imaging with Pittsburgh Compound-B; 327 individuals underwent multiple cognitive assessments, including measures of episodic memory, executive functions, verbal fluency, and processing speed.Results: Greater exercise was associated with less steep decline in processing speed. Baseline exercise did not robustly impact longitudinal change for any other outcomes. NeitherAPOEnorBDNFgenotype robustly moderated the effect of exercise on trajectories of AD biomarkers or cognitive decline.Interpretation: Results suggest that self-reported physical exercise may be limited as a moderator of changes in AD biomarkers.